The Radiology Business Journal (3/30, Walter) reported that research suggests “digital breast tomosynthesis (DBT) can help radiologists detect more architectural distortion (AD) lesions than 2D mammography alone.” The findings were published in Radiology.

The Radiology Business Journal (3/30, Walter) reported that research indicates that “two out of three women want a biopsy performed if a radiologist determines there is any chance of breast cancer.” The study “also found that women overestimate the risk of breast cancer when follow-up imaging or biopsy is recommended for low-risk mammographic abnormalities.” The findings were published in the Journal of the American College of Radiology.

Aunt Minnie (3/30, Yee) reports, “More than 80% of screening breast MRI exams are performed on women for whom the test is not necessarily recommended – that is, women with a lifetime risk for the disease of less than 20%,” according to a study published in the Journal of General Internal Medicine. “Breast MRI use that is not concordant with guidelines...poses distinct challenges to effective resource allocation in breast cancer screening,” the researchers wrote. The piece notes, “Screening breast MRI is currently recommended for women with 20% or greater lifetime breast cancer risk by the American Cancer Society (ACS), the American College of Radiology (ACR), and the Society of Breast Imaging (SBI).”

DOT Med News (3/29, Dubinsky) reports, “Patients treated with partial or reduced-dose breast radiotherapy experience fewer side effects than those who undergo whole-breast radiotherapy,” according to “research presented at the European Breast Cancer Conference.”

HealthImaging (3/29, Rohman) reports researchers “found that women with greater than minimal background parenchymal enhancement (BPE) at an index MRI face increased risk of developing breast cancer.” The findings were published in Academic Radiology.